Konstantinos Kostikas

University of Ioannina

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Christos Katsouras

University of Ioannina

GREECE

View details

Katerina Naka

Professor of Cardiology

University of Ioannina

GREECE

View details

Lampros Mihalis

Director, Profesor

University of Ioannina

GREECE

View details

Maria Kallieri

GREECE

View details

Stelios Loukides

Ass Professor

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

View details

Theodoros Karampitsakos

University of South Florida

UNITED STATES

View details

Andriana I. Papaioannou

GREECE

View details

Petros Bakakos

National and Kapodistrian University of Athens

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Konstantinos Kostikas

Research Interests

Contact this professor

Articles (11)

What is the real incidence of right ventricular affection in patients with acute pulmonary embolism?

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification

Recent Advances of Artificial Intelligence Applications in Interstitial Lung Diseases

Effectiveness and quality of life in asthmatic patients treated with budesonide/formoterol via Elpenhaler® device in primary care. The “SKIRON” real world study

Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations

Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study

Latent COPD: a proposed new term in the disease nomenclature

Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations

Collaborators (8)

Christos Katsouras

Katerina Naka

Lampros Mihalis

Maria Kallieri

Stelios Loukides

Theodoros Karampitsakos

Andriana I. Papaioannou

Petros Bakakos

Make your next move.